Tirzepatide and Cardioprotection in Type 2 Diabetes: Insights From SURPASS ‐ CVOT

The authors have nothing to report. The authors declare no conflicts of interest. Data availability is not applicable for this manuscript. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70766.